Clinical trial
Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke
NCT00507806 is registered in ClinicalTrials.gov with ImaRx Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke
- Lead sponsor
- ImaRx Therapeutics
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- March 31, 2005
- Completion date
- May 31, 2006
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke